A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system

Transmission-Blocking Vaccines: Old Friends and New Prospects

(2019) Festus K. Acquah et al.   INFECTION AND IMMUNITY

A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria

(2019) Tarlan Mamedov et al.   Scientific Reports

Expression and purification optimization of an N-terminal Pfs230 transmission-blocking vaccine candidate

(2019) Shwu-Maan Lee et al.   PROTEIN EXPRESSION AND PURIFICATION

Disulfide bond mapping of Pfs25, a recombinant malaria transmission blocking vaccine candidate

(2018) Shwu-Maan Lee et al.   ANALYTICAL BIOCHEMISTRY

Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity

(2018) Will J. R. Stone et al.   Nature Communications

Progress toward a transmission-blocking vaccine against malaria

(2018) Tomoko Ishino et al.   LANCET INFECTIOUS DISEASES

Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults

(2018) Issaka Sagara et al.   LANCET INFECTIOUS DISEASES

Antimalarial Transmission-Blocking Interventions: Past, Present, and Future

(2018) M.J. Delves et al.   TRENDS IN PARASITOLOGY

Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody

(2018) Frank Lennartz et al.   Nature Communications

Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45

(2018) Prasun Kundu et al.   Nature Communications

Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine

(2017) Michael Theisen et al.   Expert Review of Vaccines

Antibody responses to two new Lactococcus lactis-produced recombinant Pfs48/45 and Pfs230 proteins increase with age in malaria patients living in the Central Region of Ghana

(2017) Festus K. Acquah et al.   MALARIA JOURNAL

Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine

(2017) Susheel K. Singh et al.   Microbial Cell Factories

Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of thePlasmodium falciparumSexual Stage Protein Pfs230

(2016) Nicholas J. MacDonald et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates

(2016) Shwu-Maan Lee et al.   MALARIA JOURNAL

Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay

(2016) Kazutoyo Miura et al.   VACCINE

Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults

(2016) Kawsar R. Talaat et al.   PLoS One

Overcoming inefficient secretion of recombinant VEGF-C in baculovirus expression vector system by simple purification of the protein from cell lysate

(2015) Tomasz Klaus et al.   PROTEIN EXPRESSION AND PURIFICATION

Expression and Characterization of HA1 Protein of Highly Pathogenic H5N1 Avian Influenza Virus for Use in a Serodiagnostic Assay

(2015) L. Luo et al.   Transboundary and Emerging Diseases

Comparative Assessment of Transmission-Blocking Vaccine Candidates against Plasmodium falciparum

(2015) M. C. Kapulu et al.   Scientific Reports

Structural and Biochemical Characterization ofPlasmodium falciparum12 (Pf12) Reveals a Unique Interdomain Organization and the Potential for an Antiparallel Arrangement withPf41

(2013) Michelle L. Tonkin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Qualification of Standard Membrane-Feeding Assay with Plasmodium falciparum Malaria and Potential Improvements for Future Assays

(2013) Kazutoyo Miura et al.   PLoS One

Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle

(2013) Richard L. Shimp et al.   VACCINE

The concept of translocational regulation

(2008) Ramanujan S. Hegde et al.   JOURNAL OF CELL BIOLOGY

Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice

(2008) N. S. Outchkourov et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines

(2007) Kazutoyo Miura et al.   VACCINE